• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COPD 患者的慢性支气管感染。是否存在感染表型?

Chronic bronchial infection in COPD. Is there an infective phenotype?

机构信息

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Ciber de Enfermedades Respiratorias (CIBERES), Hospital Clínic, Barcelona, Spain.

出版信息

Respir Med. 2013 Jan;107(1):10-22. doi: 10.1016/j.rmed.2012.10.024. Epub 2012 Dec 4.

DOI:10.1016/j.rmed.2012.10.024
PMID:23218452
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7126218/
Abstract

Microorganisms, particularly bacteria, are frequently found in the lower airways of COPD patients, both in stable state and during exacerbations. The host-pathogen relationship in COPD is a complex, dynamic process characterised by frequent changes in pathogens, their strains and loads, and subsequent host immune responses. Exacerbations are detrimental events in the course of COPD and evidence suggests that 70% may be caused by microorganisms. When considering bacterial exacerbations, recent findings based on molecular typing have demonstrated that the acquisition of new strains of bacteria or antigenic changes in pre-existing strains are the most important triggers for exacerbation onset. Even in clinically stable COPD patients the presence of microorganisms in their lower airways may cause harmful effects and induce chronic low-grade airway inflammation leading to increased exacerbation frequency, an accelerated decline in lung function and impaired health-related quality of life. Besides intraluminal localisation in the distal airways, bacteria can be found in the bronchial walls and parenchymal lung tissue of COPD patients. Therefore, the isolation of pathogenic bacteria in stable COPD should be considered as a form of chronic infection rather than colonisation. This new approach may have important implications for the management of patients with COPD.

摘要

微生物,特别是细菌,经常在 COPD 患者的下呼吸道中被发现,无论是在稳定期还是在加重期。COPD 中的宿主-病原体关系是一个复杂的、动态的过程,其特点是病原体及其菌株和负荷经常发生变化,以及随后的宿主免疫反应。加重是 COPD 病程中的不利事件,有证据表明,70%可能由微生物引起。在考虑细菌加重时,基于分子分型的最新发现表明,新菌株的获得或原有菌株的抗原性变化是加重发作的最重要触发因素。即使在临床稳定的 COPD 患者中,下呼吸道中微生物的存在也可能造成有害影响,并导致慢性低度气道炎症,从而增加加重频率、加速肺功能下降和损害健康相关生活质量。除了在远端气道的腔内定位外,细菌还可以在 COPD 患者的支气管壁和肺实质组织中被发现。因此,稳定期 COPD 中致病性细菌的分离应被视为一种慢性感染形式,而不是定植。这种新方法可能对 COPD 患者的管理具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c610/7126218/6c4f764dfb0b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c610/7126218/6c4f764dfb0b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c610/7126218/6c4f764dfb0b/gr1_lrg.jpg

相似文献

1
Chronic bronchial infection in COPD. Is there an infective phenotype?COPD 患者的慢性支气管感染。是否存在感染表型?
Respir Med. 2013 Jan;107(1):10-22. doi: 10.1016/j.rmed.2012.10.024. Epub 2012 Dec 4.
2
Pathogenesis of bacterial exacerbations of COPD.慢性阻塞性肺疾病细菌感染加重的发病机制。
COPD. 2006 Jun;3(2):109-15. doi: 10.1080/15412550600651347.
3
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
4
Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.慢性阻塞性肺疾病全球倡议(GOLD)综合评估分期系统与细菌分离之间的关系
Int J Chron Obstruct Pulmon Dis. 2014 Sep 27;9:1045-51. doi: 10.2147/COPD.S70620. eCollection 2014.
5
The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management.慢性支气管感染对 COPD 的影响:管理建议。
Int J Chron Obstruct Pulmon Dis. 2022 Mar 23;17:621-630. doi: 10.2147/COPD.S357491. eCollection 2022.
6
Murine model of chronic respiratory inflammation.慢性呼吸炎症的鼠模型。
Adv Exp Med Biol. 2011;780:125-41. doi: 10.1007/978-1-4419-5632-3_11.
7
Bacterial colonisation of lower airways in health and chronic lung disease.健康与慢性肺病患者下呼吸道的细菌定植
Clin Respir J. 2008 Apr;2(2):116-22. doi: 10.1111/j.1752-699X.2008.00048.x.
8
[A clinical study of bacterial infection in patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病患者细菌感染的临床研究]
Zhonghua Jie He He Hu Xi Za Zhi. 1999 Feb;22(2):88-91.
9
Inflammation and chronic colonization of in sputum in COPD patients related to the degree of emphysema and bronchiectasis in high-resolution computed tomography.慢性阻塞性肺疾病(COPD)患者痰液中的炎症和慢性定植与高分辨率计算机断层扫描中肺气肿和支气管扩张的程度有关。
Int J Chron Obstruct Pulmon Dis. 2017 Nov 1;12:3211-3219. doi: 10.2147/COPD.S137578. eCollection 2017.
10
Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.泰国慢性阻塞性肺疾病(COPD)患者支气管扩张的存在与急性加重之间的关系。
Int J Chron Obstruct Pulmon Dis. 2018 Mar 2;13:761-769. doi: 10.2147/COPD.S139776. eCollection 2018.

引用本文的文献

1
Current Evidence on the Usefulness of Potential Therapies in the Prevention of COPD Exacerbations: Beyond the Use of Bronchodilator Therapy and Inhaled Corticosteroids.预防慢性阻塞性肺疾病(COPD)急性加重的潜在疗法有效性的当前证据:超越支气管扩张剂疗法和吸入性糖皮质激素的应用
Open Respir Arch. 2025 May 7;7(2):100438. doi: 10.1016/j.opresp.2025.100438. eCollection 2025 Apr-Jun.
2
Tolerance and effectiveness of inhaled antibiotics at standard or low doses in COPD patients with chronic Pseudomonas aeruginosa bronchial infection.标准剂量或低剂量吸入性抗生素对慢性铜绿假单胞菌支气管感染的慢性阻塞性肺疾病(COPD)患者的耐受性和有效性。
Sci Rep. 2025 Mar 13;15(1):8773. doi: 10.1038/s41598-025-91763-w.
3

本文引用的文献

1
Lung microbiology and exacerbations in COPD.慢性阻塞性肺疾病中的肺部微生物组学和加重情况。
Int J Chron Obstruct Pulmon Dis. 2012;7:555-69. doi: 10.2147/COPD.S28286. Epub 2012 Aug 31.
2
Efficacy of antibiotic therapy for acute exacerbations of mild to moderate chronic obstructive pulmonary disease.抗生素治疗轻中度慢性阻塞性肺疾病急性加重的疗效。
Am J Respir Crit Care Med. 2012 Oct 15;186(8):716-23. doi: 10.1164/rccm.201206-0996OC. Epub 2012 Aug 23.
3
The lung tissue microbiome in chronic obstructive pulmonary disease.慢性阻塞性肺疾病的肺部组织微生物组。
Clinical Implications of Colonization in Chronic Obstructive Pulmonary Disease Patients.
慢性阻塞性肺疾病患者定植的临床意义
Chronic Obstr Pulm Dis. 2025 Mar 27;12(2):137-145. doi: 10.15326/jcopdf.2024.0582.
4
Is There a Role for Immunostimulant Bacterial Lysates in the Management of Respiratory Tract Infection?免疫刺激细菌裂解物在呼吸道感染治疗中的作用?
Biomolecules. 2024 Oct 2;14(10):1249. doi: 10.3390/biom14101249.
5
A Systematic Review of the Pulmonary Microbiome in Patients with Acute Exacerbation COPD Requiring ICU Admission.对因急性加重慢性阻塞性肺疾病而需入住重症监护病房的患者的肺部微生物群的系统评价。
J Clin Med. 2024 Jan 15;13(2):472. doi: 10.3390/jcm13020472.
6
Microbiological Monitoring in Therapeutic Trials in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病治疗试验中的微生物监测
Am J Respir Crit Care Med. 2023 Nov 15;208(10):1142-1143. doi: 10.1164/rccm.202307-1214LE.
7
Isolation of in Stable Chronic Obstructive Pulmonary Disease Patients-Should We Treat It?稳定期慢性阻塞性肺疾病患者的隔离——我们应该治疗吗?
J Clin Med. 2023 Aug 1;12(15):5054. doi: 10.3390/jcm12155054.
8
[Chronic Bronchial Infection in Stable COPD].[稳定期慢性阻塞性肺疾病中的慢性支气管感染]
Open Respir Arch. 2023 Feb 3;5(1):100234. doi: 10.1016/j.opresp.2023.100234. eCollection 2023 Jan-Mar.
9
Factors Associated With the Development of Bacterial Pneumonia Related to Seasonal Influenza Virus Infection: A Study Using a Large-scale Health Insurance Claim Database.与季节性流感病毒感染相关的细菌性肺炎发生的相关因素:一项使用大规模健康保险理赔数据库的研究
Open Forum Infect Dis. 2023 Apr 21;10(5):ofad222. doi: 10.1093/ofid/ofad222. eCollection 2023 May.
10
Nontubercular bacterial and fungal infections in patients of chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的非结核分枝杆菌和真菌感染。
Ann Afr Med. 2023 Jan-Mar;22(1):77-81. doi: 10.4103/aam.aam_186_21.
Am J Respir Crit Care Med. 2012 May 15;185(10):1073-80. doi: 10.1164/rccm.201111-2075OC. Epub 2012 Mar 15.
4
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.慢性支气管炎加重期痰液颜色与细菌:汇总分析。
Eur Respir J. 2012 Jun;39(6):1354-60. doi: 10.1183/09031936.00042111. Epub 2011 Oct 27.
5
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.慢性阻塞性肺疾病急性加重:生物簇及其生物标志物的鉴定。
Am J Respir Crit Care Med. 2011 Sep 15;184(6):662-71. doi: 10.1164/rccm.201104-0597OC.
6
Factors associated with bronchiectasis in patients with COPD.与 COPD 患者支气管扩张相关的因素。
Chest. 2011 Nov;140(5):1130-1137. doi: 10.1378/chest.10-1758. Epub 2011 May 5.
7
The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.长期全身抗菌治疗在慢性阻塞性肺疾病中的获益。
Ther Adv Respir Dis. 2011 Jun;5(3):207-16. doi: 10.1177/1753465811398372. Epub 2011 Mar 4.
8
Analysis of the lung microbiome in the "healthy" smoker and in COPD.分析“健康”吸烟者和 COPD 患者的肺部微生物组。
PLoS One. 2011 Feb 22;6(2):e16384. doi: 10.1371/journal.pone.0016384.
9
The impact of using different symptom-based exacerbation algorithms in patients with COPD.不同基于症状的加重算法在 COPD 患者中的应用影响。
Eur Respir J. 2011 May;37(5):1260-8. doi: 10.1183/09031936.00130910. Epub 2010 Dec 22.
10
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.实验性鼻病毒感染作为慢性阻塞性肺疾病加重的人类模型。
Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42. doi: 10.1164/rccm.201006-0833OC. Epub 2010 Oct 1.